sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / Etanercept

Etanercept Market By Application (Psoriasis, Arthritis, and Spondylitis): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

  • Publish On: Mar-2020
  • Total Pages: 187
  • Report Code: FAF-944
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the etanercept industry. The report analyzes and declares the historical and current trends analysis of the etanercept industry and subsequently recommends the projected trends anticipated to be observed in the etanercept market during the upcoming years.

The etanercept market report analyzes and notifies the industry statistics at the global as well as regional and country levels to acquire a thorough perspective of the entire etanercept market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Billion) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the etanercept industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the etanercept industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the etanercept market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the etanercept industry. The etanercept market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the etanercept sector. Key strategic developments in the etanercept market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the etanercept market are appropriately highlighted in the report.

Over the forecast time period, the global etanercept market is projected to expand at a rapid rate. It is due to a rise in stiffness level, lifestyle problems, mishaps, and spondylitis commonness. Enbrel has received considerable value compared with other repair proteins. It is utilized in the treatment of auto-insusceptible sicknesses, for example, adolescent rheumatoid joint inflammation, psoriasis, and plaque. To impel the worldwide etanercept exhibition, ascend in the predominance of such illnesses is depended upon. In addition, creative headways and innovative work exercises could bring new open doors to the etanercept market worldwide.

The global etanercept market has been segmented on the basis of application, and region. On the basis of the application segment, the target market is segmented into arthritis, psoriasis, and spondylitis.

Some of the essential players operating in the market are Samsung Bioepis Co., Ltd., Pfizer Inc, Novartis International AG, Johnson & Johnson, Immunex Corporation, GlaxoSmithKline Pharmaceuticals Ltd, F. Hoffmann-La Roche Ltd, Cipla Limited, Celltrion Inc.

The taxonomy of the etanercept Market by its scope and segmentation is as follows:

Global Etanercept Market: By Application Segmentation Analysis

  • Psoriasis
  • Arthritis
  • Spondylitis

Global Etanercept Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a robust research methodology. The triangular process comprises a buoyant mix of exhaustive primary research (focused interviews, questionnaires, and ad-hoc surveys) and extended secondary research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Etanercept market – Application Analysis
    1. 2.1. Global Etanercept Market – Application Overview
    2. 2.2. Global Etanercept Market Share, by Application, 2018 & 2025 (USD Billion)
    3. 2.3. Psoriasis
      1. 2.3.1. Global Psoriasis Etanercept Market, 2016-2026 (USD Billion)
    4. 2.4. Arthritis
      1. 2.4.1. Global Arthritis Etanercept Market, 2016-2026 (USD Billion)
    5. 2.5. Spondylitis
      1. 2.5.1. Global Spondylitis Etanercept Market, 2016-2026 (USD Billion)
  3. CHAPTER 3. Etanercept market – Regional Analysis
    1. 3.1. Global Etanercept Market Regional Overview
    2. 3.2. Global Etanercept Market Share, by Region, 2018 & 2025 (Value)
    3. 3.3. North America
      1. 3.3.1. North America Etanercept Market size and forecast, 2016-2026
      2. 3.3.2. North America Etanercept Market, by Country, 2018 & 2025 (USD Billion)
      3. 3.3.3. North America Etanercept Market, by Application, 2016-2026
        1. 3.3.3.1. North America Etanercept Market, by Application, 2016-2026 (USD Billion)
      4. 3.3.4. U.S.
        1. 3.3.4.1. U.S. Market size and forecast, 2016-2026 (USD Billion)
      5. 3.3.5. Canada
        1. 3.3.5.1. Canada Market size and forecast, 2016-2026 (USD Billion)
    4. 3.4. Europe
      1. 3.4.1. Europe Etanercept Market size and forecast, 2016-2026
      2. 3.4.2. Europe Etanercept Market, by Country, 2018 & 2025 (USD Billion)
      3. 3.4.3. Europe Etanercept Market, by Application, 2016-2026
        1. 3.4.3.1. Europe Etanercept Market, by Application, 2016-2026 (USD Billion)
      4. 3.4.4. Germany
        1. 3.4.4.1. Germany Market size and forecast, 2016-2026 (USD Billion)
      5. 3.4.5. France
        1. 3.4.5.1. France Market size and forecast, 2016-2026 (USD Billion)
      6. 3.4.6. U.K.
        1. 3.4.6.1. U.K. Market size and forecast, 2016-2026 (USD Billion)
      7. 3.4.7. Italy
        1. 3.4.7.1. Italy Market size and forecast, 2016-2026 (USD Billion)
      8. 3.4.8. Spain
        1. 3.4.8.1. Spain Market size and forecast, 2016-2026 (USD Billion)
      9. 3.4.9. Rest of Europe
        1. 3.4.9.1. Rest of Europe Market size and forecast, 2016-2026 (USD Billion)
    5. 3.5. Asia Pacific
      1. 3.5.1. Asia Pacific Etanercept Market size and forecast, 2016-2026
      2. 3.5.2. Asia Pacific Etanercept Market, by Country, 2018 & 2025 (USD Billion)
      3. 3.5.3. Asia Pacific Etanercept Market, by Application, 2016-2026
        1. 3.5.3.1. Asia Pacific Etanercept Market, by Application, 2016-2026 (USD Billion)
      4. 3.5.4. China
        1. 3.5.4.1. China Market size and forecast, 2016-2026 (USD Billion)
      5. 3.5.5. Japan
        1. 3.5.5.1. Japan Market size and forecast, 2016-2026 (USD Billion)
      6. 3.5.6. India
        1. 3.5.6.1. India Market size and forecast, 2016-2026 (USD Billion)
      7. 3.5.7. South Korea
        1. 3.5.7.1. South Korea Market size and forecast, 2016-2026 (USD Billion)
      8. 3.5.8. South-East Asia
        1. 3.5.8.1. South-East Asia Market size and forecast, 2016-2026 (USD Billion)
      9. 3.5.9. Rest of Asia Pacific
        1. 3.5.9.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Billion)
    6. 3.6. Latin America
      1. 3.6.1. Latin America Etanercept Market size and forecast, 2016-2026
      2. 3.6.2. Latin America Etanercept Market, by Country, 2018 & 2025 (USD Billion)
      3. 3.6.3. Latin America Etanercept Market, by Application, 2016-2026
        1. 3.6.3.1. Latin America Etanercept Market, by Application, 2016-2026 (USD Billion)
      4. 3.6.4. Brazil
        1. 3.6.4.1. Brazil Market size and forecast, 2016-2026 (USD Billion)
      5. 3.6.5. Mexico
        1. 3.6.5.1. Mexico Market size and forecast, 2016-2026 (USD Billion)
      6. 3.6.6. Rest of Latin America
        1. 3.6.6.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Billion)
    7. 3.7. The Middle-East and Africa
      1. 3.7.1. The Middle-East and Africa Etanercept Market size and forecast, 2016-2026
      2. 3.7.2. The Middle-East and Africa Etanercept Market, by Country, 2018 & 2025 (USD Billion)
      3. 3.7.3. The Middle-East and Africa Etanercept Market, by Application, 2016-2026
        1. 3.7.3.1. The Middle-East and Africa Etanercept Market, by Application, 2016-2026 (USD Billion)
      4. 3.7.4. GCC Countries
        1. 3.7.4.1. GCC Countries Market size and forecast, 2016-2026 (USD Billion)
      5. 3.7.5. South Africa
        1. 3.7.5.1. South Africa Market size and forecast, 2016-2026 (USD Billion)
      6. 3.7.6. Rest of Middle-East Africa
        1. 3.7.6.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Billion)
  4. CHAPTER 4. Etanercept market – Competitive Landscape
    1. 4.1. Competitor Market Share – Revenue
    2. 4.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 4.3. Strategic Development
      1. 4.3.1. Acquisitions and Mergers
      2. 4.3.2. New Products
      3. 4.3.3. Research & Development Activities
  5. CHAPTER 5. Company Profiles
    1. 5.1. Samsung Bioepis Co. Ltd.
      1. 5.1.1. Company Overview
      2. 5.1.2. Samsung Bioepis Co. Ltd. Revenue and Gross Margin
      3. 5.1.3. Product portfolio
      4. 5.1.4. Recent initiatives
    2. 5.2. Pfizer Inc
      1. 5.2.1. Company Overview
      2. 5.2.2. Pfizer Inc Revenue and Gross Margin
      3. 5.2.3. Product portfolio
      4. 5.2.4. Recent initiatives
    3. 5.3. Novartis International AG
      1. 5.3.1. Company Overview
      2. 5.3.2. Novartis International AG Revenue and Gross Margin
      3. 5.3.3. Product portfolio
      4. 5.3.4. Recent initiatives
    4. 5.4. Johnson & Johnson
      1. 5.4.1. Company Overview
      2. 5.4.2. Johnson & Johnson Revenue and Gross Margin
      3. 5.4.3. Product portfolio
      4. 5.4.4. Recent initiatives
    5. 5.5. Immunex Corporation
      1. 5.5.1. Company Overview
      2. 5.5.2. Immunex Corporation Revenue and Gross Margin
      3. 5.5.3. Product portfolio
      4. 5.5.4. Recent initiatives
    6. 5.6. GlaxoSmithKline Pharmaceuticals Ltd
      1. 5.6.1. Company Overview
      2. 5.6.2. GlaxoSmithKline Pharmaceuticals Ltd Revenue and Gross Margin
      3. 5.6.3. Product portfolio
      4. 5.6.4. Recent initiatives
    7. 5.7. F. Hoffmann-La Roche Ltd
      1. 5.7.1. Company Overview
      2. 5.7.2. F. Hoffmann-La Roche Ltd Revenue and Gross Margin
      3. 5.7.3. Product portfolio
      4. 5.7.4. Recent initiatives
    8. 5.8. Cipla Limited
      1. 5.8.1. Company Overview
      2. 5.8.2. Cipla Limited Revenue and Gross Margin
      3. 5.8.3. Product portfolio
      4. 5.8.4. Recent initiatives
    9. 5.9. Celltrion Inc.
      1. 5.9.1. Company Overview
      2. 5.9.2. Celltrion Inc. Revenue and Gross Margin
      3. 5.9.3. Product portfolio
      4. 5.9.4. Recent initiatives
  6. CHAPTER 6. Etanercept — Industry Analysis
    1. 6.1. Etanercept Market – Key Trends
      1. 6.1.1. Market Drivers
      2. 6.1.2. Market Restraints
      3. 6.1.3. Market Opportunities
    2. 6.2. Value Chain Analysis
    3. 6.3. Technology Roadmap and Timeline
    4. 6.4. Etanercept Market – Attractiveness Analysis
      1. 6.4.1. By Application
      2. 6.4.2. By Region
  7. CHAPTER 7. Marketing Strategy Analysis, Distributors
    1. 7.1. Marketing Channel
    2. 7.2. Direct Marketing
    3. 7.3. Indirect Marketing
    4. 7.4. Marketing Channel Development Trend
    5. 7.5. Economic/Political Environmental Change
  8. CHAPTER 8. Report Conclusion
  9. CHAPTER 9. Research Approach & Methodology
    1. 9.1. Report Description
    2. 9.2. Research Scope
    3. 9.3. Research Methodology
      1. 9.3.1. Secondary Research
      2. 9.3.2. Primary Research
      3. 9.3.3. Models
        1. 9.3.3.1. Company Share Analysis Model
        2. 9.3.3.2. Revenue Based Modeling
        3. 9.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Etanercept Market, 2016-2026 (USD Billion)
        FIG. 2 Global Etanercept Market Share, by Application, 2018 & 2025 (USD Billion)
        FIG. 3 Global Psoriasis Etanercept Market, 2016-2026 (USD Billion)
        FIG. 4 Global Arthritis Etanercept Market, 2016-2026 (USD Billion)
        FIG. 5 Global Spondylitis Etanercept Market, 2016-2026 (USD Billion)
        FIG. 6 Global Etanercept Market Share, by Region, 2018 & 2025
        FIG. 7 North America Etanercept Market, 2016-2026
        FIG. 8 U.S. Etanercept Market, 2016-2026
        FIG. 9 Canada Etanercept Market, 2016-2026
        FIG. 10 Europe Etanercept Market, 2016-2026
        FIG. 11 Germany Etanercept Market, 2016-2026
        FIG. 12 France Etanercept Market, 2016-2026
        FIG. 13 U.K. Etanercept Market, 2016-2026
        FIG. 14 Italy Etanercept Market, 2016-2026
        FIG. 15 Spain Etanercept Market, 2016-2026
        FIG. 16 Rest of Europe Etanercept Market, 2016-2026
        FIG. 17 Asia Pacific Etanercept Market, 2016-2026
        FIG. 18 China Etanercept Market, 2016-2026
        FIG. 19 Japan Etanercept Market, 2016-2026
        FIG. 20 India Etanercept Market, 2016-2026
        FIG. 21 South  Korea Etanercept Market, 2016-2026
        FIG. 22 South-East Asia Etanercept Market, 2016-2026
        FIG. 23 Rest of Asia Pacific Etanercept Market, 2016-2026
        FIG. 24 Latin America Etanercept Market, 2016-2026
        FIG. 25 Brazil Etanercept Market, 2016-2026
        FIG. 26 Mexico Etanercept Market, 2016-2026
        FIG. 27 Rest of Latin America Etanercept Market, 2016-2026
        FIG. 28 The Middle-East and Africa Etanercept Market, 2016-2026
        FIG. 29 GCC Countries Etanercept Market, 2016-2026
        FIG. 30 South Africa Etanercept Market, 2016-2026
        FIG. 31 Rest of Middle-East Africa Etanercept Market, 2016-2026
        FIG. 32 Competitor Market Share – Revenue
        FIG. 33 Samsung Bioepis Co. Ltd. Revenue and Growth Rate
        FIG. 34 Samsung Bioepis Co. Ltd. Market Share
        FIG. 35 Pfizer Inc Revenue and Growth Rate
        FIG. 36 Pfizer Inc Market Share
        FIG. 37 Novartis International AG Revenue and Growth Rate
        FIG. 38 Novartis International AG Market Share
        FIG. 39 Johnson & Johnson Revenue and Growth Rate
        FIG. 40 Johnson & Johnson Market Share
        FIG. 41 Immunex Corporation Revenue and Growth Rate
        FIG. 42 Immunex Corporation Market Share
        FIG. 43 GlaxoSmithKline Pharmaceuticals Ltd Revenue and Growth Rate
        FIG. 44 GlaxoSmithKline Pharmaceuticals Ltd Market Share
        FIG. 45 F. Hoffmann-La Roche Ltd Revenue and Growth Rate
        FIG. 46 F. Hoffmann-La Roche Ltd Market Share
        FIG. 47 Cipla Limited Revenue and Growth Rate
        FIG. 48 Cipla Limited Market Share
        FIG. 49 Celltrion Inc. Revenue and Growth Rate
        FIG. 50 Celltrion Inc. Market Share
        FIG. 51 Market Dynamics
        FIG. 52 Global Etanercept – Value Chain Analysis
        FIG. 53 Technology Roadmap and Timeline
        FIG. 54 Market Attractiveness Analysis – By Application
        FIG. 55 Market Attractiveness Analysis – By Region
        FIG. 56 Market Channel
        FIG. 57 Marketing Channel Development Trend
        FIG. 58 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Global Etanercept Market, 2018 & 2025 (USD Billion)
        TABLE 2 Global Etanercept market, by Application, 2016-2026 (USD Billion)
        TABLE 3 Global Etanercept market, by Region, 2016-2026 (USD Billion)
        TABLE 4 North America Etanercept Market, by Application, 2016-2026 (USD Billion)
        TABLE 5 Europe Etanercept Market, by Application, 2016-2026 (USD Billion)
        TABLE 6 Asia Pacific Etanercept Market, by Application, 2016-2026 (USD Billion)
        TABLE 7 Latin America Etanercept Market, by Application, 2016-2026 (USD Billion)
        TABLE 8 The Middle-East and Africa Etanercept Market, by Application, 2016-2026 (USD Billion)
        TABLE 9 Global Etanercept Market - Company Revenue Analysis 2016-2026 (USD Billion)
        TABLE 10 Global Etanercept Market - Company Revenue Share Analysis 2016-2026(%)
        TABLE 11 Acquisitions and Mergers
        TABLE 12 New Product/Service Launch
        TABLE 13 Research & Development Activities
        TABLE 14 Market Drivers
        TABLE 15 Market Restraints
        TABLE 16 Market Opportunities
        

Key Insights from Primary Research

  • As per our primary respondents, the global etanercept market is set to grow annually at a rate of around xx%.
  • It was established through primary research that the global etanercept market was valued at around USD xx Billion in 2019.
  • The “arthritis” category, on the basis of application segmentation, was the leading revenue-generating category in 2019.
  • Based on the region, North America was the leading revenue-generating category in 2019.

Key Recommendations from Analysts

  • As per our analysis, the global etanercept market is growing at high CAGR and various end-use industries are aware of this potential market and applications of the etanercept.
  • Growing at a CAGR around xx%, the global etanercept market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
  • Our analysts have identified arthritis segment will be dominating for global etanercept market in terms of application segmentation.
  • As per our analysis, North America is expected to account for maximum revenue share, in the target market.

Etanercept Market

Industry Major Market Players

  •  Samsung Bioepis Co.Ltd.
  •  Pfizer Inc
  •  Novartis International AG
  •  Johnson & Johnson
  •  Immunex Corporation
  •  GlaxoSmithKline Pharmaceuticals Ltd
  •  F. Hoffmann-La Roche Ltd
  •  Cipla Limited
  •  Celltrion Inc.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions